← 返回专利悬崖列表
CAS 2627-86-3
(S)-1-phenylethan-1-amine(S)-(-)-1-Phenylethylamine
登记编号：APER-019、Amoxicillin-002、LEFA-007、POSA-049、(II)145089-6-a、(II)145089-19-a、(III)145089-20-a、(XII)989842-2-b
应用背景（按来源药适应症）
斑块银屑病阿普米司特白塞病综合征阿普米司特口腔溃疡阿普米司特银屑病阿普米司特银屑病关节炎阿普米司特幽门螺杆菌感染阿莫西林/奥美拉唑/利福布汀消化不良阿莫西林/奥美拉唑/利福布汀感染来法莫林社区获得性感染来法莫林细菌性肺炎来法莫林肺炎来法莫林社区获得性肺炎来法莫林囊性纤维化来法莫林十二指肠溃疡雷贝拉唑钠/甲硝唑/阿莫西林特发性血小板减少性紫癜雷贝拉唑钠/甲硝唑/阿莫西林胃溃疡雷贝拉唑钠/甲硝唑/阿莫西林胃炎雷贝拉唑钠/甲硝唑/阿莫西林幽门螺杆菌感染雷贝拉唑钠/甲硝唑/阿莫西林边缘带B细胞淋巴瘤克拉霉素/雷贝拉唑钠/阿莫西林十二指肠溃疡克拉霉素/雷贝拉唑钠/阿莫西林特发性血小板减少性紫癜克拉霉素/雷贝拉唑钠/阿莫西林胃溃疡克拉霉素/雷贝拉唑钠/阿莫西林胃炎克拉霉素/雷贝拉唑钠/阿莫西林幽门螺杆菌感染克拉霉素/雷贝拉唑钠/阿莫西林念珠菌病泊沙康唑曲霉菌属感染泊沙康唑真菌感染泊沙康唑口腔念珠菌病泊沙康唑球孢菌病泊沙康唑组织胞浆菌病泊沙康唑细菌感染阿莫西林钠阿尔茨海默病重酒石酸卡巴拉汀痴呆重酒石酸卡巴拉汀帕金森病重酒石酸卡巴拉汀抗胆碱能综合征重酒石酸卡巴拉汀神经行为学表现重酒石酸卡巴拉汀认知障碍重酒石酸卡巴拉汀斑块银屑病莫米司特溃疡性结肠炎莫米司特白塞病综合征莫米司特银屑病莫米司特慢性阻塞性肺疾病莫米司特特应性皮炎莫米司特
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| 阿普米司特Apremilast | Tier B · 提前布局 | 2028 |
| 阿莫西林/奥美拉唑/利福布汀Amoxicillin/Omeprazole/Rifabutin | Tier C · 观察 / 贸易 | - |
| 来法莫林Lefamulin | Tier C · 观察 / 贸易 | - |
| 雷贝拉唑钠/甲硝唑/阿莫西林Rabeprazole Sodium/Metronidazole/Amoxicillin | Tier C · 观察 / 贸易 | - |
| 克拉霉素/雷贝拉唑钠/阿莫西林Clarithromycin/Rabeprazole Sodium/Amoxicillin | Tier C · 观察 / 贸易 | - |
| 泊沙康唑Posaconazole | Tier C · 观察 / 贸易 | - |
| 阿莫西林钠Amoxicillin Sodium | Tier C · 观察 / 贸易 | - |
| 重酒石酸卡巴拉汀Rivastigmine Tartrate | Tier B · 提前布局 | - |
| 莫米司特Mufemilast | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
3-ethoxy-4-methoxybenzaldehyde→3-ethoxy-4-methoxybenzonitrile→(S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine→(E)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine→1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanone→(S)-1-phenylethan-1-amine→1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)-N-((S)-1-phenylethyl)ethanamine hydrochloride→(R)-2-methylpropane-2-sulfinamide→(E)-N-(3-ethoxy-4-methoxybenzylidene)-2-methylpropane-2-sulfinamide→N-((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2-methylpropane-2-sulfinamide
Methyl glyoxylate→(S)-(-)-1-Phenylethylamine→(1S)-1-(2-Naphthyl)ethanamine→Methyl (2Z)-[[(1S)-1-phenylethyl]imino]acetate→Methyl (2Z)-[[(1S)-1-(naphthalen-2-yl)ethyl]imino]acetate→Carbolic acid→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate hydrogen chloride (1/1)→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate hydrogen chloride (1/1)→D-p-Hydroxyphenylglycine methyl ester hydrochloride→D-p-yHdroxyphenylglycine methyl ester→(+)-6-Aminopenicillanic acid
(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(((1R,2R,4R)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclohexyl)thio)acetate→cyclohex-3-ene-1-carboxylic acid→(S)-1-phenylethan-1-amine→(S)-1-phenylethan-1-aminium (R)-cyclohex-3-ene-1-carboxylate→(R)-cyclohex-3-ene-1-carboxylic acid→tert-butyl (R)-cyclohex-3-en-1-ylcarbamate→tert-butyl ((1R,3R,6S)-7-oxabicyclo[4.1.0]heptan-3-yl)carbamate→S-((1R,2R,4R)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclohexyl) benzothioate→tert-butyl ((1R,3R,4R)-3-hydroxy-4-mercaptocyclohexyl)carbamate→(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate
Methyl glyoxylate→(S)-(-)-1-Phenylethylamine→(1S)-1-(2-Naphthyl)ethanamine→Methyl (2Z)-[[(1S)-1-phenylethyl]imino]acetate→Methyl (2Z)-[[(1S)-1-(naphthalen-2-yl)ethyl]imino]acetate→Carbolic acid→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate hydrogen chloride (1/1)→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate hydrogen chloride (1/1)→D-p-Hydroxyphenylglycine methyl ester hydrochloride→D-p-yHdroxyphenylglycine methyl ester→(+)-6-Aminopenicillanic acid
Methyl glyoxylate→(S)-(-)-1-Phenylethylamine→(1S)-1-(2-Naphthyl)ethanamine→Methyl (2Z)-[[(1S)-1-phenylethyl]imino]acetate→Methyl (2Z)-[[(1S)-1-(naphthalen-2-yl)ethyl]imino]acetate→Carbolic acid→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate→Methyl (2R)-(4-hydroxyphenyl)[(1-phenylethyl)amino]acetate hydrogen chloride (1/1)→Methyl (2R)-(4-hydroxyphenyl)[[1-(naphthalen-2-yl)ethyl]amino]acetate hydrogen chloride (1/1)→D-p-Hydroxyphenylglycine methyl ester hydrochloride→D-p-yHdroxyphenylglycine methyl ester→(+)-6-Aminopenicillanic acid
本站可供应的对应中间体
目录暂未收录该靶点的在售中间体 —— 可直接发起询价，需求会进入撮合池。
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。